journal
MENU ▼
Read by QxMD icon Read
search

Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America

journal
https://www.readbyqxmd.com/read/27852623/january-1-2017-news
#1
(no author information available yet)
No abstract text is available yet for this article.
November 16, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27838645/therapeutic-immune-recovery-prevents-emergence-of-cxcr4-tropic-hiv-1
#2
Joëlle Bader, Martin Däumer, Franziska Schöni-Affolter, Jürg Böni, Meri Gorgievski-Hrisoho, Gladys Martinetti, Alexander Thielen, Thomas Klimkait
BACKGROUND: In the absence of therapy CXCR4-tropic HIV-1 increases over time, associated with accelerated disease progression. In contrast, the majority of patients under long-term cART presents with CCR5-tropic HIV-1 variants. It is unclear, whether cART itself mediates the reduction of CXCR4-tropic HIV-1. This study aimed at assessing the tropism of viral integrates in patients' blood during fully suppressive cART. METHODS: Relative frequencies of CXCR4-tropic proviral HIV-1 variants were determined by NGS (FPR3...
November 12, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27821546/are-people-living-near-modern-swine-production-facilities-at-increased-risk-of-influenza-virus-infection
#3
Paul M Lantos, Kate Hoffman, Michael Höhle, Benjamin Anderson, Gregory C Gray
BACKGROUND:  Swine can harbor influenza viruses that are pathogenic to humans. Previous studies support an increased risk of human influenza cases among individuals with swine contact. North Carolina has the second-largest swine industry in the United States. METHODS:  We investigated the spatiotemporal association between influenza-like illnesses (ILIs) and licensed swine operations from 2008 to 2012 in North Carolina. We determined the week in which ILI cases peaked and statistically estimated their week of onset...
November 6, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27815292/decision-science-at-work-the-case-of-hepatitis-c-virus-postexposure-prophylaxis
#4
EDITORIAL
Joshua A Barocas, Benjamin P Linas
No abstract text is available yet for this article.
November 3, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27803096/inhaled-antibiotics-for-hospital-acquired-and-ventilator-associated-pneumonia
#5
LETTER
Lindsay M Daniels, Jonathan Juliano, Ashley Marx, David J Weber
No abstract text is available yet for this article.
November 1, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27803095/reply-to-daniels-et-al
#6
LETTER
Lucy B Palmer, Daniel A Sweeney, Mark L Metersky, Andre C Kalil
No abstract text is available yet for this article.
November 1, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27803094/fluconazole-in-the-treatment-of-cutaneous-leishmaniasis-caused-by-leishmania-braziliensis-a-randomized-controlled-trial
#7
Fernanda V de O Prates, Mayra E F Dourado, Silvana C Silva, Albert Schriefer, Luiz H Guimarães, Maria das Graças O Brito, Juliana Almeida, Edgar M Carvalho, Paulo R L Machado
BACKGROUND:  The treatment of cutaneous leishmaniasis (CL) caused by Leishmania braziliensis in Brazil with pentavalent antimony (Sb(v)) is associated with a high rate of failure, up to 45% of cases. In addition, Sb(v) can only administered parenterally and has important toxic effect. An effective, safe, and oral treatment for CL is required. METHODS:  A randomized controlled clinical trial was conducted to compare the efficacy and safety of high-dosage oral fluconazole (6...
November 1, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27794019/latent-toxoplasma-infection-and-higher-toxoplasma-gondii-immunoglobulin-g-levels-are-associated-with-worse-neurocognitive-functioning-in-hiv-infected-adults
#8
Ajay R Bharti, Allen McCutchan, Reena Deutsch, Davey M Smith, Ronald J Ellis, Mariana Cherner, Steven P Woods, Robert K Heaton, Igor Grant, Scott L Letendre
BACKGROUND:  Human immunodeficiency virus (HIV)-associated neurocognitive disorders persist despite suppressive antiretroviral therapy (ART). Because latent Toxoplasma infection (LTI) may adversely impact brain function, we investigated its impact on neurocognitive impairment (NCI) in people living with HIV disease. METHODS:  Two hundred sixty-three HIV-infected adults underwent comprehensive neurocognitive assessments and had anti-Toxoplasma gondii immunoglobulin G (anti-Toxo IgG) measured by qualitative and quantitative enzyme-linked immunosorbent assays...
October 28, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27789608/something-new-for-community-acquired-pneumonia
#9
LETTER
Lionel A Mandell
No abstract text is available yet for this article.
October 27, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27789607/oxford-specialist-handbook-of-infectious-disease-epidemiology
#10
Louise Elaine Vaz
No abstract text is available yet for this article.
October 27, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27789610/reply-to-alffenaar-et-al
#11
LETTER
Charles A Peloquin, Susan E Dorman, Andrew Vernon, Giovanni Battista Migliori, Payam Nahid
No abstract text is available yet for this article.
October 26, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27737954/time-until-emergence-of-hiv-test-reactivity-following-infection-with-hiv-1-implications-for-interpreting-test-results-and-retesting-after-exposure
#12
Kevin P Delaney, Debra L Hanson, Silvina Masciotra, Steven F Ethridge, Laura Wesolowski, S Michele Owen
BACKGROUND:  Understanding the period of time between an exposure resulting in infection with HIV and when a test can reliably detect the presence of that infection, i.e. the test window period, may benefit testing programs and clinicians in counseling patients about when the clinician and the patient can be confident a suspected exposure did not result in HIV infection. METHODS:  We evaluated the intervals between reactivity of the Aptima HIV-1 RNA nucleic acid test (Aptima) and 20 FDA-approved HIV immunoassays using 222 longitudinally collected plasma specimens from HIV-1 seroconverters from the United States...
October 12, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27737953/late-relapse-versus-hcv-reinfection-in-patients-with-sustained-virologic-response-after-sofosbuvir-based-therapies
#13
Christoph Sarrazin, Vasily Isakov, Evguenia Svarovskaia, Charlotte Hedskog, Ross Martin, Krishna Chodavarapu, Diana M Brainard, Michael D Miller, Hongmei Mo, Jean-Michel Molina, Mark S Sulkowski
BACKGROUND:  Development of direct-acting antivirals in recent years has dramatically enhanced rates of viral eradication to >90% in patients with chronic hepatitis C virus (HCV) infection. To determine true treatment efficacy and to define the most appropriate retreatment, it is important to distinguish virologic relapse from reinfection where patients who achieve HCV eradication during treatment become infected with a new HCV strain posttreatment. METHODS:  Here, we investigated prevalence of late recurrent viremia (patients who achieved SVR12 but had detectable HCV RNA at follow up week 24) and used refined phylogenetic analysis of multiple HCV genes to distinguish virologic relapse from reinfection...
October 12, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27737952/initiation-of-antiretroviral-therapy-in-early-hiv-infection-reduces-but-does-not-abrogate-chronic-residual-inflammation
#14
Irini Sereti, Shelly J Krebs, Nittaya Phanuphak, James L Fletcher, Bonnie Slike, Suteeraporn Pinyakorn, Robert J O'Connell, Adam Rupert, Nicolas Chomont, Victor Valcour, Jerome H Kim, Merlin L Robb, Nelson L Michael, Daniel C Douek, Jintanat Ananworanich, Netanya S Utay
BACKGROUND:  Serious non-AIDS events cause substantial morbidity and mortality despite HIV suppression with antiretroviral therapy (ART). Biomarkers of inflammation, coagulation cascade activation, and fibrosis predict these end-organ events. We aimed to determine whether ART initiation during acute HIV infection would attenuate changes in these biomarker levels. METHODS:  Plasma samples were obtained from participants starting ART during acute HIV infection, chronic HIV infection, and HIV-uninfected participants, from Bangkok, Thailand...
October 12, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27810866/cutaneous-and-visceral-chronic-granulomatous-disease-triggered-by-a-rubella-virus-vaccine-strain-in-children-with-primary-immunodeficiencies
#15
Bénédicte Neven, Philippe Pérot, Julie Bruneau, Marlene Pasquet, Marie Ramirez, Jean-Sébastien Diana, Stéphanie Luzi, Nicole Corre-Catelin, Christophe Chardot, Despina Moshous, Stéphanie Leclerc Mercier, Nizar Mahlaoui, Nathalie Aladjidi, Brigitte Le Bail, Marc Lecuit, Christine Bodemer, Thierry Jo Molina, Stéphane Blanche, Marc Eloit
Persistence of rubella live vaccine has been associated with chronic skin granuloma in 3 children with primary immunodeficiency. We describe 6 additional children with these findings, including 1 with visceral extension to the spleen.
October 6, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27794024/antimicrobial-resistance-a-call-to-action
#16
LETTER
Lillian Brown, Charles Langelier, Michael J A Reid, Rachel L Rutishauser, Luke Strnad
No abstract text is available yet for this article.
October 6, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27794023/the-effectiveness-and-safety-of-high-dose-colistin-prospective-cohort-study
#17
Yael Dishon Benattar, Muna Omar, Oren Zusman, Dafna Yahav, Yael Zak-Doron, Sergey Altunin, Michal Elbaz, Vered Daitch, Michal Granot, Leonard Leibovici, Mical Paul
BACKGROUND:  Optimizing colistin dosing should translate to improved patient outcomes. METHODS:  We used data from 2 prospective cohort studies performed between 2006 and 2009 and between 2012 and 2015. In the latter period, a new policy of high-dose colistin (9 million international units [MIU] loading dose followed by 9 MIU daily for normal renal function) was introduced in 2 participating hospitals. We included adult inpatients with invasive infections caused by carbapenem-resistant gram-negative bacteria treated with colistin...
October 6, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27794022/colistin-dosing-does-the-fun-ever-start
#18
EDITORIAL
Jason M Pogue, Jessica K Ortwine, Keith S Kaye
No abstract text is available yet for this article.
October 6, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27794021/the-point-of-antimicrobial-susceptibility-testing-is-to-inform-antimicrobial-prescribing
#19
LETTER
Kayla R Stover, Christopher M Bland, Jason C Gallagher
No abstract text is available yet for this article.
October 6, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/27794020/turkey-meat-as-source-of-cc9-cc398-methicillin-resistant-staphylococcus-aureus-in-humans
#20
LETTER
Alexandra Fetsch, Britta Kraushaar, Annemarie Käsbohrer, Jens André Hammerl
No abstract text is available yet for this article.
October 6, 2016: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
journal
journal
20074
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"